TIFFANY SHANAHAN: Open Payments
NPI 1750818894 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 26 payments from 10 companies in 2025. Trend: 2023 $568 · 2024 $882 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $163 |
| Astellas Pharma US Inc | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Amgen Inc. | 3 | $45 |
| Novo Nordisk Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: NURTEC ODT, Veozah, Ozempic, MOUNJARO, AIRSUPRA, REPATHA, INSPIRE, SHINGRIX.
Industry payments across AR — which companies pay providers there.
